Buy Laurus Labs: target of Rs 450: Sharekhan

Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 450 in its research report dated March 10, 2021.

March 12, 2021 / 08:57 AM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Laurus Labs

Formulations business on a strong footing to grow backed by opportunities in the US while diversification to non ARV areas – anti diabetics and cardiology to fuel API growth. Sturdy growth prospects, visibility on earnings, healthy return ratios and low debt-equity are the key positives. Over a long term horizon of 3-5 years, Laurus has charted out its growth trajectory encompassing all segments & management aspires grow its revenues beyond $1bn in size.


We retain a Buy recommendation on Laurus Labs Limited (Laurus) with a revised PT of Rs. 450.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Mar 12, 2021 08:57 am

stay updated

Get Daily News on your Browser